bioAffinity Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIAF and other ETFs, options, and stocks.About BIAF
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells.
CEOMaria Zannes
CEOMaria Zannes
Employees57
Employees57
HeadquartersSan Antonio, Texas
HeadquartersSan Antonio, Texas
Founded2014
Founded2014
Employees57
Employees57
BIAF Key Statistics
Market cap12.54M
Market cap12.54M
Price-Earnings ratio-0.13
Price-Earnings ratio-0.13
Dividend yield—
Dividend yield—
Average volume2.39M
Average volume2.39M
High today$2.71
High today$2.71
Low today$2.55
Low today$2.55
Open price$2.62
Open price$2.62
Volume146.69K
Volume146.69K
52 Week high$46.53
52 Week high$46.53
52 Week low$2.34
52 Week low$2.34
BIAF News
TipRanks 5d
bioAffinity Technologies Presents at CHEST 2025 ConferenceElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
People also own
Based on the portfolios of people who own BIAF. This list is generated using Robinhood data, and it’s not a recommendation.